MCM
BPMC

MAI Capital Management’s Blueprint Medicines BPMC Stock Holding History

MAI Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9
Closed -$1.15K – 3842
2025
Q2 		$1.15K Buy
9
+3
+50% +$312 ﹤0.01% 3581
2025
Q1 		$532 Buy
+6
New +$585 ﹤0.01% 3228

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAI Capital Management's BPMC Position: Q3 2025 in Review

MAI Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 9 shares — an estimated $1.15K sold.

MAI Capital Management first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $1.15K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • MAI Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • MAI Capital Management sold 9 Blueprint Medicines shares in Q3 2025, an estimated $1.15K.
  • MAI Capital Management first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
  • MAI Capital Management's Blueprint Medicines position peaked at $1.15K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on MAI Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.